Polaryx Therapeutics, Inc. (PLYX)
Polaryx Therapeutics Market Cap : 80.25M for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 18, 2026 | 80.25M |
| November 17, 2026 | 79.75M |
| November 16, 2026 | 83.24M |
| November 13, 2026 | 88.23M |
| November 12, 2026 | 93.71M |
| November 11, 2026 | 97.20M |
| November 10, 2026 | 93.21M |
| November 09, 2026 | 96.70M |
| November 06, 2026 | 89.72M |
| November 05, 2026 | 86.73M |
| November 04, 2026 | 89.72M |
| November 03, 2026 | 86.23M |
| November 02, 2026 | 87.23M |
| October 30, 2026 | 87.23M |
| October 29, 2026 | 92.71M |
| October 28, 2026 | 94.21M |
| October 27, 2026 | 93.71M |
| October 26, 2026 | 90.72M |
| October 23, 2026 | 92.22M |
| October 22, 2026 | 96.70M |
| October 21, 2026 | 96.70M |
| October 20, 2026 | 95.21M |
| October 19, 2026 | 95.70M |
| October 16, 2026 | 93.71M |
| October 15, 2026 | 97.20M |
| Date | Value |
|---|---|
| October 14, 2026 | 98.20M |
| October 13, 2026 | 96.70M |
| October 12, 2026 | 100.19M |
| October 09, 2026 | 99.69M |
| October 08, 2026 | 99.69M |
| October 07, 2026 | 104.18M |
| October 06, 2026 | 104.68M |
| October 05, 2026 | 103.18M |
| October 02, 2026 | 103.68M |
| October 01, 2026 | 100.69M |
| September 30, 2026 | 103.18M |
| September 29, 2026 | 103.18M |
| September 28, 2026 | 101.69M |
| September 25, 2026 | 104.18M |
| September 24, 2026 | 106.67M |
| September 23, 2026 | 106.67M |
| September 22, 2026 | 107.17M |
| September 21, 2026 | 106.67M |
| September 18, 2026 | 101.69M |
| September 17, 2026 | 106.67M |
| September 16, 2026 | 101.19M |
| September 15, 2026 | 101.94M |
| September 14, 2026 | 100.69M |
| September 11, 2026 | 100.19M |
| September 10, 2026 | 99.19M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 18.82M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| GB Sciences, Inc. | 0.0407M |
| Arvinas, Inc. | 443.11M |
| Fulcrum Therapeutics, Inc. | 284.14M |
Market Cap Related Metrics
| PEG Ratio | -2.087 |
| Price to Book Value | 10.54 |
| Price | 1.61 |
| Earnings Yield | -11.24% |
| PEGY Ratio | -2.087 |